ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

PTGX Protagonist Therapeutics Inc

25,60
0,04 (0,16%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,04 0,16% 25,60 00:07:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
25,74 25,28 26,21 25,54 25,56
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202415:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
02.3.202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202402:27EDGAR2Form 144 - Report of proposed sale of securities
01.3.202422:32EDGAR2Form 144 - Report of proposed sale of securities
29.2.202423:48EDGAR2Form 144 - Report of proposed sale of securities
29.2.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:12EDGAR2Form 8-K - Current report
14.2.202413:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202413:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202422:05EDGAR2Form 8-K - Current report
19.1.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202414:01EDGAR2Form 8-K - Current report
12.1.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202423:25EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:00EDGAR2Form 8-K - Current report
05.1.202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02.11.202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:40EDGAR2Form 8-K - Current report
30.10.202321:30EDGAR2Form 8-K - Current report
23.10.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03.8.202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:13EDGAR2Form 8-K - Current report
05.7.202314:00EDGAR2Form 8-K - Current report
03.7.202322:06EDGAR2Form 8-K - Current report
12.5.202313:00PRNUSProtagonist Reports Positive Results from Phase 1 and..
11.5.202322:05PRNUSProtagonist Therapeutics to Participate in the JMP..
11.5.202316:17PRNUSProtagonist Therapeutics Announces Presentations at the 2023..
04.5.202322:05PRNUSProtagonist Reports First Quarter 2023 Financial Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock